Cargando…
Serum S100B Protein Levels in Patients with Panic Disorder: Effect of Treatment with Selective Serotonine Reuptake Inhibitors
OBJECTIVE: Altered serum S100B protein levels have been shown in several psychiatric disorders. Our aim was to investigate whether plasma S100B is different in patients with panic disorder (PD) when compared with controls. Our second aim was to investigate whether treatment with SSRIs have an effect...
Autores principales: | Cagatay Kaya, Berna, Karadag, Hasan, Oner, Ozgur, Kart, Aysegul, Turkcapar, Mehmet Hakan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390598/ https://www.ncbi.nlm.nih.gov/pubmed/25866528 http://dx.doi.org/10.4306/pi.2015.12.2.260 |
Ejemplares similares
-
It is never too late to treat anxiety neurosis or panic disorder with a serotonin-reuptake inhibitor
por: Bech, Per, et al.
Publicado: (2014) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021) -
Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996) -
Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019) -
Heart Rate Recovery and Selective Serotonin Reuptake
Inhibitors
por: Cerit, Levent
Publicado: (2016)